Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

NCT02792816 · clinicaltrials.gov ↗

COMPLETED

Status

550

Enrollment

OTHER

Sponsor class

Conditions

Drug Resistance
Plasmodium Falciparum Malaria

Interventions

DRUG: First line antimalarial in Myanmar (artemether-lumefrantrine, dihydroartemisinin-piperaquine, and artesunate-mefloquine)

Sponsor

Department of Medical Research, Lower Myanmar

Collaborators

[object Object]